JOMPAC

Journal of Medicine and Palliative Care (JOMPAC) is an open access scientific journal with independent, unbiased, and double-blind review under international guidelines. The purpose of JOMPAC is to contribute to the literature by publishing articles on health sciences and medicine.

EndNote Style
Index
Case Report
A rare complication of central fascial paralysis associated with quinolone
Quinolones, which are broad-spectrum antibiotics, are frequently preferred in the treatment of infections. In infections developing in immunosuppressed patients, side effects of quinolones, which are started empirically without determining the agent and etiology, are also quite common. In this article, central facial paralysis due to ciprofloxacin initiated for anal abscess in an immunosuppressed patient receiving chemotherapy for multiple myeloma is described, and we aim to draw attention to this rare side effect. To the best of our knowledge, this is the first case reported in the literature.


1. Shariati A, Arshadi M, Khosrojerdi MA, et al. The resistancemechanisms of bacteria against ciprofloxacin and new approachesfor enhancing the efficacy of this antibiotic. Frontiers PublicHealth. 2022;10:1025633. doi: 10.3389/fpubh.2022.1025633
2. Ali AK. Peripheral neuropathy and Guillain-Barré syndromerisks associated with exposure to systemic fluoroquinolones: apharmacovigilance analysis. Ann Epidemiol. 2014;24(4):279-285.
3. Stahlmann R, Lode H. Toxicity of quinolones. Drugs. 1999;58(Suppl 2):37-42.
4. Mennander AA. The dark side of fluoroquinolones. J ThoracicCardiovasc Surg. 2019;157(1):122-123.
5. Refaeian A, Vest EL, Schmidt M, et al. Ciprofloxacin-inducedperipheral neuropathy: a case report. HCA Healthcare J Med.2023;4(5):7.
6. Bates D, Edwards J, Justin C, Fisher M, Switzer A, Morris C.Fluoroquinolone induced movement disorders: case report andliterature review. Ulutas Med J. 2020;4(1):53-63.
7. Lee C-h, Cheung RT-f, Chan T-m. Ciprofloxacin-induced oralfacial dyskinesia in a patient with normal liver and renal function.Hospital Med. 2000;61(2):142-143.
8. Azar S, Ramjiani A, Van Gerpen JA. Ciprofloxacin-inducedchorea. Movement Disord. 2005;20(4):513-514.
9. Isaacson SH, Carr J, Rowan AJ. Ciprofloxacin-induced complexpartial status epilepticus manifesting as an acute confusionalstate. Neurol. 1993;43(8):1619-1619.
10. Staff NP, Dyck PJB. On the association between fluoroquinolonesand neuropathy. JAMA Neurol. 2019;76(7):753-754.
11. Etminan M, Brophy JM, Samii A. Oral fluoroquinolone use andrisk of peripheral neuropathy: a pharmacoepidemiologic study.Neurol. 2014;83(14):1261-1263.
12. Manji H. Drug-induced neuropathies. Handbook Clin Neurol.2013;115:729-742. doi.org/10.1016/B978-0-444-52902-2.00042-4
13. Jones MR, Urits I, Wolf J, et al. Drug-induced peripheralneuropathy: a narrative review. Curr Clin Pharmacol. 2020;15(1):38-48.
14. Morales D, Pacurariu A, Slattery J, Pinheiro L, McGettigan P, KurzX. Association between peripheral neuropathy and exposure tooral fluoroquinolone or amoxicillin-clavulanate therapy. JAMANeurol. 2019;76(7):827-833.
15. Cheung YF, Wong WWY, Tang KW, Chan JHM, Li PCK.Ciprofloxacin-induced palatal tremor. Movement Disord.2007;22(7):1038-1043.
16. Ben-Chetrit E, Rothstein N, Munter G. Ciprofloxacin-inducedpsychosis. Antimicrobial Agents Chemother. 2013;57(8):4079-4079.
17. Dukewich M, Danesh A, Onyima C, Gupta A. Intractable acutepain related to fluoroquinolone-induced peripheral neuropathy. JPain Palliat Care Pharmacother. 2017;31(2):144-147.
18. Estofan LJ, Naydin S, Gliebus G. Quinolone-inducedpainful peripheral neuropathy: a case report and literaturereview. J Investigative Med High Impact Case Reports.2018;6:2324709617752736. doi:10.1177/2324709617752736
Volume 4, Issue 6, 2023
Page : 718-720
_Footer